期刊文献+

对比剂肾病研究进展 被引量:12

The research progress of contrast media induced nephropathy
下载PDF
导出
摘要 随着造影技术在临床的广泛应用,特别是在高龄、有严重合并症患者中的应用,如糖尿病、肾功能衰竭、心功能衰竭、容量不足等患者,使对比剂肾病(contrast induced nephropathy,CIN)成为医院获得性肾功能衰竭的第三大主要原因,占发病率的11%。本文主要介绍有关CIN病理生理学方面的实验室研究进展、CIN危险因子等方面的重要临床资料的研究进展以及预防策略及各种药物治疗的研究进展。 As a result of the increasing use of radiologic contrast medium in patients, especially the elderly in severe or clinical condition with attendant comorbidities, such as diabetes mellitus, renal failure, cardiac failure, and volume depletion. Contrast induced nephropathy(CIN)is now the third most common cause of hospital-aquired renal failure and accounts for approximately 11% of the cases, This article mainly introduces the evaluation of laboratory investigations providing insights into the pathophysiology of this disorder and the examination of the important clinical data of CIN including risk factors and diagnosis. The last section deals with renal protection and preventive strategies.
出处 《介入放射学杂志》 CSCD 2007年第1期66-69,共4页 Journal of Interventional Radiology
关键词 对比剂相关肾病 病理生理 危险因素 预测 预防 Contrast induced nephropathy Pathophysiology Risk factor Prediction Prophylaxis
  • 相关文献

参考文献28

  • 1Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency[J].Am J Kidney Dis,2002,39:930-936.
  • 2McCullough PA,Sandberg KR.Epidemiology of contrast-induced nephropathy[J].Rev Cardiovasc Med,2003,4(suppl 5):S3 -S9.
  • 3Thomsen HS,Morcos SK.Contrast media and the kidney.European Society of Urogenital Radiology (ESUR) guidelines[J].Br J Radiol,2003,76:513-518.
  • 4倪钧,沈卫峰,张瑞岩,张奇,张宪,郑爱芳.非离子型造影剂在肾动脉介入治疗中的安全性研究[J].介入放射学杂志,2004,13(2):137-139. 被引量:16
  • 5Denton KM,Whweta A,Anderson WP.Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia[J].J Am Soc Nephrol,2002,13:27 -34.
  • 6Prasad PV,Priatna A,Spokes K,et al.Changes in intra-renal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy[J].J Magn Reson Imaging,2001,13:744-747.
  • 7Nircis SK.Prevention of contrast media nephrotoxicity-the story so far[J].Clin Radiol,2004,59:381-389.
  • 8Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention[J].Circulation,2002,105:2259-2264.
  • 9National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39:S1-266.
  • 10Szczech LA,Best P,Crowley E,et al.Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation[J].Circulation,2002,105:2253-2258.

二级参考文献20

  • 1Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J, 2003, 4(10):668-676.
  • 2Nash K, Hafeez A, Hou S. Hospital acquired renal insufficiency. Am J Kidney Dis, 2002, 39:930-936.
  • 3Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002, 105:2259-2264.
  • 4McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors,and relationship to mortality. Am J Med, 1997, 103:368-375.
  • 5Rudnick MR, Berns JS, Cohen RM, et al. Nephro-toxic risks of renal angiography: contrast media-associated nephrotoxicity ang atheroembolism-a critical review. Am J Kidney Dis, 1994, 24:713-727.
  • 6Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med, 1989, 86:649-652.
  • 7Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med, 1990, 150:1237-1242.
  • 8Nikolsky E, Mehram R. Understanding the consequences of contrast-induced nephropathy. Reu Cardiovasc Med, 2003,4(Suppl 5):S10-S18.
  • 9Kini AS, Mitre CA, Kim M, et al. A protocal for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptoragonist fenoldopan. Catheter Cardiovasc Interv, 2002, 55:169-173.
  • 10Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention[J]. J Vasc Intern Radiol, 2001;12:3-9.

共引文献63

同被引文献140

引证文献12

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部